Basic Information
Basic information for MIR9-3HG-217-23aa
Peptide Name MIR9-3HG-217-23aa
Genome Position chr15:89395153-89395221[+]
Species Human
Peptide Sequence MQEPQKGKKPSRKGEQVASVLKL
Peptide Length 23
Unique No (MIR9-3HG-201-23aa-1,MIR9-3HG-202-23aa,MIR9-3HG-203-23aa,MIR9-3HG-204-23aa,MIR9-3HG-205-23aa,MIR9-3HG-207-23aa,MIR9-3HG-208-23aa,MIR9-3HG-211-23aa,MIR9-3HG-212-23aa-1,MIR9-3HG-213-23aa-1,MIR9-3HG-214-23aa-1,MIR9-3HG-215-23aa,MIR9-3HG-218-23aa-1,MIR9-3HG-219-23aa-1,MIR9-3HG-220-23aa-1,MIR9-3HG-221-23aa-1,MIR9-3HG-222-23aa-1,MIR9-3HG-223-23aa,MIR9-3HG-224-23aa,MIR9-3HG-225-23aa,MIR9-3HG-226-23aa-2,MIR9-3HG-227-23aa-1,MIR9-3HG-228-23aa,MIR9-3HG-229-23aa,MIR9-3HG-231-23aa,MIR9-3HG-232-23aa,MIR9-3HG-233-23aa-1,MIR9-3HG-234-23aa,MIR9-3HG-235-23aa,MIR9-3HG-236-23aa,MIR9-3HG-237-23aa,MIR9-3HG-238-23aa,MIR9-3HG-239-23aa,MIR9-3HG-240-23aa,MIR9-3HG-241-23aa-1,MIR9-3HG-242-23aa,MIR9-3HG-243-23aa,MIR9-3HG-244-23aa,MIR9-3HG-245-23aa,MIR9-3HG-246-23aa-2,MIR9-3HG-247-23aa-1,MIR9-3HG-248-23aa,MIR9-3HG-249-23aa,MIR9-3HG-251-23aa-1,MIR9-3HG-252-23aa-2,MIR9-3HG-253-23aa-1)
Grand Average of Hydropathicity -1.1913
Relative Molecular Mass 2963.38
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000656907;MIR9-3HG-217
Transcript Length 982
Coding Ability 0.6253
DNA Sequence Corresponding to Peptide ATGCAAGAGCCTCAGAAGGGAAAAAAGCCCAGCAGGAAGGGAGAACAAGTAGCCTCTGTCCTGAAGTTG
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :